Insys Therapeutics Receives Subpoena From Office of Inspector General

Insys Therapeutics, Inc. (NASDAQ: INSY ) announced today that it has received a subpoena from the Office of Inspector General of the Department of Health and Human Services ("HHS") in connection with an investigation of potential violations involving HHS programs. The subpoena requests documents regarding Subsys(R), including Insys' sales and marketing practices relating to this